Pacific Capital Partners Ltd Takes Position in ICU Medical, Inc. (NASDAQ:ICUI)

Pacific Capital Partners Ltd acquired a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 92,500 shares of the medical instruments supplier's stock, valued at approximately $12,845,000. ICU Medical comprises 8.1% of Pacific Capital Partners Ltd's portfolio, making the stock its 2nd largest holding. Pacific Capital Partners Ltd owned approximately 0.38% of ICU Medical as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Quarry LP raised its stake in shares of ICU Medical by 764.3% during the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after buying an additional 214 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after buying an additional 300 shares during the last quarter. GAMMA Investing LLC grew its holdings in ICU Medical by 27.2% during the 1st quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock valued at $99,000 after buying an additional 153 shares during the last quarter. Sterling Capital Management LLC grew its holdings in ICU Medical by 813.5% during the 4th quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock valued at $105,000 after buying an additional 602 shares during the last quarter. Finally, Blue Trust Inc. grew its holdings in ICU Medical by 23.0% during the 1st quarter. Blue Trust Inc. now owns 801 shares of the medical instruments supplier's stock valued at $111,000 after buying an additional 150 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ICUI has been the topic of a number of analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Raymond James Financial decreased their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday, May 9th. KeyCorp decreased their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Finally, Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, ICU Medical presently has an average rating of "Buy" and a consensus price target of $192.67.

Insider Transactions at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 4,985 shares of the company's stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $128.50, for a total value of $640,572.50. Following the transaction, the chief operating officer owned 6,088 shares of the company's stock, valued at approximately $782,308. This represents a 45.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David C. Greenberg sold 1,942 shares of the company's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $143.66, for a total value of $278,987.72. Following the completion of the transaction, the director directly owned 6,760 shares in the company, valued at $971,141.60. This represents a 22.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold 36,097 shares of company stock worth $4,860,156 in the last three months. 1.50% of the stock is currently owned by company insiders.

ICU Medical Stock Down 0.8%

NASDAQ:ICUI traded down $1.01 during mid-day trading on Friday, reaching $127.40. The stock had a trading volume of 242,242 shares, compared to its average volume of 180,698. The company has a market capitalization of $3.14 billion, a price-to-earnings ratio of -33.26 and a beta of 0.88. ICU Medical, Inc. has a 1-year low of $117.92 and a 1-year high of $196.26. The stock's 50 day simple moving average is $130.62 and its two-hundred day simple moving average is $141.74. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.59 and a quick ratio of 1.52.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 EPS for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The company had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. During the same period in the previous year, the firm posted $0.96 earnings per share. ICU Medical's quarterly revenue was up 6.7% compared to the same quarter last year. Equities analysts anticipate that ICU Medical, Inc. will post 4.11 EPS for the current year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.